Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05144152 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)

Study acronym: M3-AA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years later Dec 15, 2024 → Dec 31, 2028
See other at-risk trials from Chinese University of Hong Kong

Record History

  1. Primary completion pushed from Dec 15, 2024 to Dec 31, 2028 Trial status changed: Unknown → Recruiting · Completion pushed from Jun 15, 2025 to Dec 31, 2028 · Eligibility criteria expanded, about 12 words · 2 more Show 5 more changesShow less
    • Trial status changed: Unknown → Recruiting
    • Completion pushed from Jun 15, 2025 to Dec 31, 2028
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 1 of 4 entries
    • Publications: details revised at 12 of 12 entries
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Trial status: Recruiting to Unknownv7
  4. 2 versions Re-verified since Jul 22, 2022, no change to tracked fieldsv5-v6
  5. Enrollment target: 1667 to 600 Eligibility criteria shortened, about 28 words · Secondary endpoints revised (4) · Study description shortened, about 5 wordsv4 Show 3 more changesShow less
    • Eligibility criteria shortened, about 28 words
    • Secondary endpoints revised (4)
    • Study description shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Dec 15, 2021 to Dec 13, 2021 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Dec 15, 2021 to Dec 13, 2021
    • Site details revised
  2. Interventions: Colonoscopy (Procedure), FIT (Diagnostic Test), M3 (Diagnostic Test) to FIT (Diagnostic Test), M3 (Diagnostic Test) Eligibility criteria expanded, about 1 word · Study description shortened, about 1 wordv2 Show 2 more changesShow less
    • Eligibility criteria expanded, about 1 word
    • Study description shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators aim to evaluate the diagnostic accuracy of FIT and the novel panel of four bacterial gene markers collectively named as M3, to detect recurrent advanced adenomas in patients with history of colonic adenomas.
Trial Details
NCT Number NCT05144152
Lead Sponsor Chinese University of Hong Kong
Conditions Colorectal Adenoma, Advanced Adenoma, Colorectal Polyp
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov